272 related articles for article (PubMed ID: 33933013)
1. The healthcare costs of antimicrobial resistance in Lebanon: a multi-centre prospective cohort study from the payer perspective.
Iskandar K; Roques C; Hallit S; Husni-Samaha R; Dirani N; Rizk R; Abdo R; Yared Y; Matta M; Mostafa I; Matta R; Salameh P; Molinier L
BMC Infect Dis; 2021 May; 21(1):404. PubMed ID: 33933013
[TBL] [Abstract][Full Text] [Related]
2. Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms.
Neidell MJ; Cohen B; Furuya Y; Hill J; Jeon CY; Glied S; Larson EL
Clin Infect Dis; 2012 Sep; 55(6):807-15. PubMed ID: 22700828
[TBL] [Abstract][Full Text] [Related]
3. Healthcare-Associated Infections Due to Multidrug-Resistant Organisms: a Surveillance Study on Extra Hospital Stay and Direct Costs.
Giraldi G; Montesano M; Napoli C; Frati P; La Russa R; Santurro A; Scopetti M; Orsi GB
Curr Pharm Biotechnol; 2019; 20(8):643-652. PubMed ID: 30961489
[TBL] [Abstract][Full Text] [Related]
4. Costs and Mortality Associated With Multidrug-Resistant Healthcare-Associated Acinetobacter Infections.
Nelson RE; Schweizer ML; Perencevich EN; Nelson SD; Khader K; Chiang HY; Chorazy ML; Blevins A; Ward MA; Samore MH
Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1212-8. PubMed ID: 27406609
[TBL] [Abstract][Full Text] [Related]
5. Direct medical burden of antimicrobial-resistant healthcare-associated infections: empirical evidence from China.
Liu X; Cui D; Li H; Wang Q; Mao Z; Fang L; Ren N; Sun J
J Hosp Infect; 2020 Jun; 105(2):295-305. PubMed ID: 31931043
[TBL] [Abstract][Full Text] [Related]
6. Increased financial burdens and lengths of stay in patients with healthcare-associated infections due to multidrug-resistant bacteria in intensive care units: A propensity-matched case-control study.
Su LH; Chen IL; Tang YF; Lee JS; Liu JW
PLoS One; 2020; 15(5):e0233265. PubMed ID: 32421700
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of infections and antimicrobial use in the acute-care hospital setting in the Middle East: Results from the first point-prevalence survey in the region.
Alothman A; Al Thaqafi A; Al Ansary A; Zikri A; Fayed A; Khamis F; Al Salman J; Al Dabal L; Khalife N; AlMusawi T; Alfouzan W; El Zein S; Kotb R; Ghoneim Y; Kanj SS
Int J Infect Dis; 2020 Dec; 101():249-258. PubMed ID: 33031939
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit.
Axente C; Licker M; Moldovan R; Hogea E; Muntean D; Horhat F; Bedreag O; Sandesc D; Papurica M; Dugaesescu D; Voicu M; Baditoiu L
BMC Infect Dis; 2017 May; 17(1):358. PubMed ID: 28532467
[TBL] [Abstract][Full Text] [Related]
9. Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria.
Mauldin PD; Salgado CD; Hansen IS; Durup DT; Bosso JA
Antimicrob Agents Chemother; 2010 Jan; 54(1):109-15. PubMed ID: 19841152
[TBL] [Abstract][Full Text] [Related]
10. Comparing methods to estimate incremental inpatient costs and length of stay due to methicillin-resistant Staphylococcus aureus in Alberta, Canada.
Kirwin E; Varughese M; Waldner D; Simmonds K; Joffe AM; Smith S
BMC Health Serv Res; 2019 Oct; 19(1):743. PubMed ID: 31651305
[TBL] [Abstract][Full Text] [Related]
11. Costs of healthcare-associated infections to the Brazilian public Unified Health System in a tertiary-care teaching hospital: a matched case-control study.
Osme SF; Almeida APS; Lemes MF; Barbosa WO; Arantes A; Mendes-Rodrigues C; Gontijo Filho PP; Ribas RM
J Hosp Infect; 2020 Oct; 106(2):303-310. PubMed ID: 32693085
[TBL] [Abstract][Full Text] [Related]
12. Estimating length of stay and inpatient charges attributable to hospital-acquired bloodstream infections.
Zhang Y; Du M; Johnston JM; Andres EB; Suo J; Yao H; Huo R; Liu Y; Fu Q
Antimicrob Resist Infect Control; 2020 Aug; 9(1):137. PubMed ID: 32811557
[TBL] [Abstract][Full Text] [Related]
13. Hospital-acquired infections in Belgian acute-care hospitals: an estimation of their global impact on mortality, length of stay and healthcare costs.
Vrijens F; Hulstaert F; Devriese S; van de Sande S
Epidemiol Infect; 2012 Jan; 140(1):126-36. PubMed ID: 21320376
[TBL] [Abstract][Full Text] [Related]
14. A multi-center nested case-control study on hospitalization costs and length of stay due to healthcare-associated infection.
Lü Y; Cai MH; Cheng J; Zou K; Xiang Q; Wu JY; Wei DQ; Zhou ZH; Wang H; Wang C; Chen J
Antimicrob Resist Infect Control; 2018; 7():99. PubMed ID: 30116526
[TBL] [Abstract][Full Text] [Related]
15. Hospital-acquired infections in Belgian acute-care hospitals: financial burden of disease and potential cost savings.
Trybou J; Spaepen E; Vermeulen B; Porrez L; Annemans L
Acta Clin Belg; 2013; 68(3):199-205. PubMed ID: 24156220
[TBL] [Abstract][Full Text] [Related]
16. One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System.
Hsu JL; Siroka AM; Smith MW; Holodniy M; Meduri GU
Int J Infect Dis; 2011 Jun; 15(6):e382-7. PubMed ID: 21393043
[TBL] [Abstract][Full Text] [Related]
17. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods.
Roberts RR; Scott RD; Hota B; Kampe LM; Abbasi F; Schabowski S; Ahmad I; Ciavarella GG; Cordell R; Solomon SL; Hagtvedt R; Weinstein RA
Med Care; 2010 Nov; 48(11):1026-35. PubMed ID: 20940650
[TBL] [Abstract][Full Text] [Related]
18. A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study.
Touat M; Opatowski M; Brun-Buisson C; Cosker K; Guillemot D; Salomon J; Tuppin P; de Lagasnerie G; Watier L
Appl Health Econ Health Policy; 2019 Jun; 17(3):381-389. PubMed ID: 30506456
[TBL] [Abstract][Full Text] [Related]
19. Increases in mortality, length of stay, and cost associated with hospital-acquired infections in trauma patients.
Glance LG; Stone PW; Mukamel DB; Dick AW
Arch Surg; 2011 Jul; 146(7):794-801. PubMed ID: 21422331
[TBL] [Abstract][Full Text] [Related]
20. Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality.
Maseda E; Ramírez S; Picatto P; Peláez-Peláez E; García-Bernedo C; Ojeda-Betancur N; Aguilar G; Forés B; Solera-Marín J; Aliaño-Piña M; Tamayo E; Ramasco F; García-Álvarez R; González-Lisorge A; Giménez MJ; Suárez-de-la-Rica A;
PLoS One; 2019; 14(9):e0223092. PubMed ID: 31557256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
